Migraine affects approximately two million people in Portugal, representing a significant health condition in the country. However, despite the high prevalence, the disease continues to be underdiagnosed, meaning that many people who suffer from this problem do not receive an adequate diagnosis.
It is essential to promote a correct diagnosis and adequate monitoring for those who suffer from this disease. Early recognition of symptoms is essential so that patients can have access to appropriate treatment and improve their quality of life.
Although migraine has no cure, it can be treated and controlled through appropriate therapeutic approaches. The goal of treatment is to reduce the frequency and intensity of attacks, thus minimizing the impact of the disease on patients' daily lives.
